AMB FUBINACA

Buy AMB FUBINACA

Buy AB-FUBINACA (AMB-FUBINACA is a psychoactive drug that acts as a potent agonist for the cannabinoid receptors, with K_i values of 0.9 nM at CB₁ and 23.2 nM at CB₂ and EC₅₀ values of 1.8 nM at CB₁ and 3.2 nM at CB₂.it was originally developed by Pfizer in 2009 as an analgesic medication, but was never pursued for human use. In 2012, it was discovered as an ingredient in synthetic cannabinoid blends in  along with a related compound AB-PINACA, which had not previously been reported.

Its use has been linked to hospitalizations and deaths

AMB FUBINACA (also known as FUB-AMB and MMB-FUBINACA) is a synthetic cannabinoid based on indazoles that is a powerful agonist of the CB1 receptor and has been sold as a designer drug on the internet.